Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Haustermans

Showing results (101-110 of 285) with videos related to

Pageof 29
Sort By:
Clinical Journal of Gastroenterology|April 12, 2021
A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapyMiha Orazem, Cédric Draulans, Mathieu Spaas, et al.
International Journal of Oncology|October 23, 2019
Targeting the Hedgehog pathway in combination with X‑ray or carbon ion radiation decreases migration of MCF‑7 breast cancer cellsKatrien Konings, Niels Belmans, Randy Vermeesen, et al.
Acta Oncologica (Stockholm, Sweden)|July 1, 2010
The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancerMaarten Lambrecht, Christophe Deroose, Sarah Roels, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancerGilles Defraene, Laura Van den Bergh, Abrahim Al-Mamgani, et al.
Physics and Imaging in Radiation Oncology|March 24, 2025
Potential of automated online adaptive proton therapy to reduce margins for oesophageal cancerPascal Herbst, Camille Draguet, Ana M Barragán-Montero, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2002
Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trialKarin Stellamans, Yolande Lievens, Philippe Lambin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 12, 2008
[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour modelLudwig Dubois, Willy Landuyt, Lieselotte Cloetens, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2009
EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomachOscar Matzinger, Erich Gerber, Zvi Bernstein, et al.
Acta Oncologica (Stockholm, Sweden)|July 30, 2020
Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort studyCédric Draulans, Nancy Van Damme, Sofie Isebaert, et al.
Medical Physics|April 4, 2017
Modeling the dose dependence of the vis-absorption spectrum of EBT3 GafChromic™ filmsMaarten B Callens, Wouter Crijns, Tom Depuydt, et al.
Pageof 29

Showing results (101-110 of 285) with videos related to

Sort By:
Pageof 29
Clinical Journal of Gastroenterology|April 12, 2021
A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapyMiha Orazem, Cédric Draulans, Mathieu Spaas, et al.
International Journal of Oncology|October 23, 2019
Targeting the Hedgehog pathway in combination with X‑ray or carbon ion radiation decreases migration of MCF‑7 breast cancer cellsKatrien Konings, Niels Belmans, Randy Vermeesen, et al.
Acta Oncologica (Stockholm, Sweden)|July 1, 2010
The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancerMaarten Lambrecht, Christophe Deroose, Sarah Roels, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancerGilles Defraene, Laura Van den Bergh, Abrahim Al-Mamgani, et al.
Physics and Imaging in Radiation Oncology|March 24, 2025
Potential of automated online adaptive proton therapy to reduce margins for oesophageal cancerPascal Herbst, Camille Draguet, Ana M Barragán-Montero, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2002
Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trialKarin Stellamans, Yolande Lievens, Philippe Lambin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 12, 2008
[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour modelLudwig Dubois, Willy Landuyt, Lieselotte Cloetens, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 21, 2009
EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomachOscar Matzinger, Erich Gerber, Zvi Bernstein, et al.
Acta Oncologica (Stockholm, Sweden)|July 30, 2020
Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort studyCédric Draulans, Nancy Van Damme, Sofie Isebaert, et al.
Medical Physics|April 4, 2017
Modeling the dose dependence of the vis-absorption spectrum of EBT3 GafChromic™ filmsMaarten B Callens, Wouter Crijns, Tom Depuydt, et al.
Pageof 29